Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutrophil Gelatinase-Associated Lipocalin(NGAL): Early Biomarker of Acute Kidney Injury After Cardiac Surgery

NCT00594919 is registered in ClinicalTrials.gov with Hospital de Base as lead sponsor.

NCT NCT00594919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00594919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutrophil Gelatinase-Associated Lipocalin(NGAL): Early Biomarker of Acute Kidney Injury After Cardiac Surgery
Lead sponsor
Hospital de Base
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2007
Completion date
Not reported
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early acute kidney injury